Whole Body MRI in Oncology

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 26, 2023

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2031

Conditions
LymphomaAdvanced Prostate CancerAdvanced Breast CancerMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaMultiple Myeloma
Interventions
DIAGNOSTIC_TEST

Whole Body-Magnetic Resonance Imaging (WB-MRI)

"This is a non-pharmacological, observational, prospective, study. Each patient will undergo quantitative WB-MRI as per clinical routine. WB-MRI may be performed:~* at staging~* at follow-up Disease progression is defined by clinicians taking into account all imaging modalities and clinicolaboratorial data available for the patients."

Trial Locations (3)

20141

NOT_YET_RECRUITING

IRCCS Istituto Europeo di Oncologia S.r.l., Milan

40138

RECRUITING

IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola, Bologna

47014

RECRUITING

"IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - IRST S.r.l.", Meldola

All Listed Sponsors
lead

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

OTHER